Drugs / Clarix Flo
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06096597 | Jul 2024 → Jun 2026 overdue | interstitial cystitis | David Sheyn | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Clarix FLO | “Amniotic membranes, Clarix FLO™, have been used to assist in wound healing in many fields of medicine” NCT06096597 ↗ |
| Modality | Other / unclassified | “Clarix FLO™ is a sterile, particulate human amniotic membrane and umbilical cord tissue product” NCT06096597 ↗ |
| Route | Other | “underwent intradetrusor injections of micronized amniotic membranes” NCT06096597 ↗ |